title: Is anti-tumor necrosis factor therapy associated with increased mortality in patients with severe sepsis caused by pneumonia?
authors.forename: Stephan
authors.initials: S
authors.lastname: Harbarth
authors.forename: Jorge
authors.initials: J
authors.lastname: Garbino
authors.forename: Didier
authors.initials: D
authors.lastname: Pittet
authors.forename: Jérome
authors.initials: J
authors.lastname: Pugin
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use*; D015331:Cohort Studies; D004311:Double-Blind Method; D006801:Humans; D007769:Lactams / Q000627:therapeutic use; D051379:Mice; D011018:Pneumonia, Pneumococcal / Q000150:complications / Q000188:drug therapy / Q000276:immunology / Q000401:mortality*; D012189:Retrospective Studies; D018805:Sepsis / Q000188:drug therapy / Q000276:immunology / Q000401:mortality*; D016019:Survival Analysis; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
chemical_list: D000900:Anti-Bacterial Agents; D000906:Antibodies; D007769:Lactams; D014409:Tumor Necrosis Factor-alpha